In this family, the most significant variant was within APOB, a gene which has been extensively studied in the context of hyperlipidemia, allowing ex vivo functional studies to be designed which were able to establish a difference between the wild-type and mutant proteins, lending strong support to this variant as the causative mutation in this family. Here, APOB is linked to hyperlipidemia.